Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in dahl salt-sensitive rats

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 219-224

  Lin, Kuei Fu ^a   Chao, Julie ^a   Chao, Lee ^a  

^a Dept of Biochem and Molec Biology ^*

Author keywords

Adenovirus; Blood pressure; Gene delivery; Hypertrophy, aortic; Rats, Dahl; Stroke

Indexed keywords

ATRIAL NATRIURETIC FACTOR ALPHA; IODINE 125; VIRUS VECTOR;

ADENOVIRUS; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; GENE TARGETING; GENE THERAPY; HYPERTENSION; HYPERTROPHY; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; STROKE; VASCULAR SMOOTH MUSCLE;

EID: 0032898484     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.219     Document Type: Article

References (35)

1. Barnett HJM, Mohr JP, Stein BM, Yatsu FM. Stroke: Pathophysiology, Diagnosis, and Management. New York, NY: Churchill Livingstone; 1992:3-24.
2. Dumbovy ML, Bach Y, Rita P. In: S Waxman, ed. Functional Recovery in Neurological Disease. New York, NY: Raven; 1988:265-276.
3. Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med. 1985;313: 1330-1340.
4. Needleman P, Greenwald JE. Atriopeptin: a cardiac hormone intimately involved in fluid, electrolyte, and blood-pressure homeostasis. N Engl J Med. 1986;314:828-834.
5. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological actions of atrial natriuretic peptide. Physiol Rev. 1990;70: 665-699.
6. Atlas S, Maack T. Atrial natriuretic factor. In: EE Windhager, ed. Handbook of Physiology: Renal Physiology. New York, NY: Oxford University Press; 1992:1577-1673.
7. Tan ACITL, Russel FGM, Thien T, Benraad TJ. Atrial natriuretic peptide: an overview of clinical pharmacology and pharmacokinetics. Clin Pharmacokinet. 1993;24:28-45.
8. Vicente E, Maria JT, Jose M, Raquel F-D, Jose E, Arturo FC. High plasma levels of endothelin-1 and atrial natriuretic peptide in patients with acute ischemic stroke. Am J Hypertens. 1994;7:1085-1089.
9. Steardo L, Nathanson JA. Brain barrier tissues: end organs for atriopeptins. Science. 1987;235:470-473.
10. Friedl A, Harmening C, Schmalz F, Schuricht B, Schiller M, Hamprecht B. Elevation by atrial natriuretic factor of cyclic GMP levels in astroglia-rich cultures from murine brain. J Neurochem. 1989;52:589-597.
11. Nakao N, Itakura T, Yokote H, Nakai K, Komai N. Effect of atrial natriuretic peptide on ischemic brain edema. Acta Neurochir Suppl (Wien). 1990;51:201-203.
12. Naruse S, Aoki Y, Takei R, Horikawa Y, Ueda S. Effects of atrial natriuretic peptide on ischemic brain edema in rats evaluated by proton magnetic resonance method. Stroke. 1991;22:61-65.
13. O'Donnell ME. Regulation of Na-Cl-K cotransport in endothelial cells by atrial natriuretic factors. Am J Physiol. 1989;257:C36-C44.
14. Rubattu S, Lee M, Russo R, Enea I, Gigante B, Volpe M, Linderpainter K. Differential structural and functional characteristics of the ANP gene as a candidate for STR2, a QTL linked to stroke in SHRSP. Hypertension. 1997;30(pt 1):476. Abstract.
15. Jeffs B, Clark JS, Anderson NH, Gratton J, Brosnan MJ, Reid JL, Macrae M, Dominczak AF. Sensitivity to cerebral ischemic insult in the stroke-prone spontaneously hypertensive rat (SHRSP) is determined by a single genetic locus. Hypertension. 1997;30(pt 1):475. Abstract.
16. Knudsen KD, Dahl LK, Thompson K, Iwai J, Heine M, Leitl G. Effects of chronic excess salt ingestion. J Exp Med. 1970;132:976-1000.
17. Werber AH, Baumbach GL, Wagner DV, Mark AL, Heistad DD. Factors that influence stroke in Dahl salt-sensitive rats. Hypertension. 1985;7:59-64.
18. Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy and renal injury in salt-sensitive rats. Hum Gene Ther. 1998;9:1429-1438.
19. Lin KF, Chao J, Chao L. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension. 1995;26: 847-853.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-275.
21. Smeda JS. Hemorrhagic stroke development in spontaneously hypertensive rats fed a North American, Japanese-style diet. Stroke. 1989;20: 1212-1218.
22. Smeda JS. Cerebral vascular changes associated with hemorrhagic stroke in hypertension. Can J Physiol Pharmacol. 1992;70:552-564.
23. Bederson JB, Pitts LH. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
24. 125I-atrial natriuretic factor binding sites in the brain. Neuroendocrinology. 1986;44:365-372.
25. Chinkers M, Garbers DL, Chang MS, Lowe DG, Chin H, Goeddel DV, Schulz S. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor. Nature. 1989;338:78-83.
26. Betz AL, Ennis SR, Schielke GP. Blood-brain barrier sodium transport limits development of brain edema during partial ischemia in gerbils. Stroke. 1989;20:1253-1259.
27. Uehara Y, Hirawa N, Kawabata AY, Suzuki T, Ohshima N, Oka K, Ikeda T, Goto A, Toyo-Oka T, Kizuki K, Omata M. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Hypertension. 1994;24:770-778.
28. Raji L, Azar S, Keane WF. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26: 137-143.
29. Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension. 1995;25:227-234.
30. Cahill PA, Hassid A. Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells. Biochem Biophys Res Commun. 1991;179:1606-1613.
31. Wolf G, Thaiss F, Schoeppe W, Stahl RA. Angiotensin II-induced proliferation of cultured murine mesangial cells: inhibitory role of atrial natriuretic peptide. J Am Soc Nephrol. 1992;3:1270-1278.
32. Chen LM, Chao L, Chao J. Adenovirus-mediated delivery of human kallikrein-binding gene reduces blood pressure of spontaneously hypertensive rats. Hum Gene Ther. 1997;8:341-347.
33. Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res. 1995;77:7-13.
34. Ooboshi H, Rios CD, Heistad DD. Novel methods for adenovirus-mediated gene transfer to blood vessels in vivo. Mol Cel Biochem. 1997;172:37-46.
35. Doran SE, Ren XD, Betz AL, Pagel MA, Neuwelt EA, Roessler BJ, Davidson BL. Gene expression from recombinant viral vectors in the central nervous system after blood-brain barrier disruption. Neurosurgery. 1995;36:965-970.